Cargando…

Correction: Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma

Detalles Bibliográficos
Autores principales:	Gao, Xiaoge, Jiang, Pin, Zhang, Qian, Liu, Qian, Jiang, Shuangshuang, Liu, Ling, Guo, Maomao, Cheng, Qian, Zheng, Junnian, Yao, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111641/ https://www.ncbi.nlm.nih.gov/pubmed/37069683 http://dx.doi.org/10.1186/s13046-023-02669-2

Ejemplares similares

Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma
por: Gao, Xiaoge, et al.
Publicado: (2019)

Combination of Peglated-H1/HGFK1 Nanoparticles and TAE in the Treatment of Hepatocellular Carcinoma
por: Gao, Dazhi, et al.
Publicado: (2022)

H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma
por: Zhang, Wenyan, et al.
Publicado: (2018)

Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
por: Li, Weidong, et al.
Publicado: (2021)

Comparison of radiofrequency ablation combined with sorafenib or sorafenib alone in patients with ECOG performance score 1: identifying optimal candidates
por: Liu, Lei, et al.
Publicado: (2020)

Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity
por: Gao, Xiaoge, et al.
Publicado: (2023)

Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022)

Correction: Biodegradable reduce expenditure bioreactor for augmented sonodynamic therapy via regulating tumor hypoxia and inducing pro‑death autophagy
por: Zou, Weijuan, et al.
Publicado: (2022)

Correction to: Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N(6)-methyladenosine of PARP1 mRNA and downregulating PTEN
por: Yang, Lei, et al.
Publicado: (2021)

The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells
por: Wang, Li, et al.
Publicado: (2019)

Oxidative Stress Activated by Sorafenib Alters the Temozolomide Sensitivity of Human Glioma Cells Through Autophagy and JAK2/STAT3-AIF Axis
por: Wei, Jianwei, et al.
Publicado: (2021)

Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression
por: Decaens, Thomas, et al.
Publicado: (2021)

Sorafenib induces autophagy and suppresses activation of human macrophage
por: Lin, Jiunn-Chang, et al.
Publicado: (2013)

Comparative efficacy and safety of sunitinib vs sorafenib in renal cell carcinoma: A systematic review and meta-analysis
por: Liu, Xiu-Lan, et al.
Publicado: (2020)

Correction: Acute exposure to gold nanoparticles aggravates lipopolysaccharide-induced liver injury by amplifying apoptosis via ROS-mediated macrophage-hepatocyte crosstalk
por: Yang, Yongjun, et al.
Publicado: (2023)

IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy
por: Chai, Dafei, et al.
Publicado: (2022)

Correction: Regulation of FN1 degradation by p62/SQSTM1-dependent autophagy–lysosomal pathway in HNSCC
por: Liu, Xinchen, et al.
Publicado: (2021)

Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
por: Yao, Leyi, et al.
Publicado: (2022)

Correction: Chen et al. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers 2021, 13, 3227
por: Chen, Ming-Yao, et al.
Publicado: (2023)

Correction: The Autophagy Receptor TAX1BP1 and the Molecular Motor Myosin VI Are Required for Clearance of Salmonella Typhimurium by Autophagy
por: Tumbarello, David A., et al.
Publicado: (2016)

Correction: PLGA-microspheres-carried circGMCL1 protects against Crohn’s colitis through alleviating NLRP3 inflammasome-induced pyroptosis by promoting autophagy
por: Zhao, Jie, et al.
Publicado: (2022)

Modulation of Autophagy by Sorafenib: Effects on Treatment Response
por: Prieto-Domínguez, Nestor, et al.
Publicado: (2016)

Correction: Sirt1 coordinates with ERα to regulate autophagy and adiposity
por: Tao, Zhipeng, et al.
Publicado: (2023)

Correction: Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
Publicado: (2020)

Correction to: The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats
por: Karbownik, Agnieszka, et al.
Publicado: (2021)

Therapeutic effect and adverse reaction of sorafenib in the treatment of advanced renal cancer
por: Qiu, Juhui, et al.
Publicado: (2019)

Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib
por: Li, Senlin, et al.
Publicado: (2023)

Correction: BCAT1 binds the RNA-binding protein ZNF423 to activate autophagy via the IRE1-XBP-1-RIDD axis in hypoxic PASMCs
por: Xin, Wei, et al.
Publicado: (2021)

Correction for: The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2019)

Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
por: Hajiev, Saur, et al.
Publicado: (2021)

The Roles of Solute Carriers in Auditory Function
por: Qian, Fuping, et al.
Publicado: (2022)

Publisher Correction: NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells
por: Zhu, Lingqun, et al.
Publicado: (2019)

CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma
por: Lu, Shuai, et al.
Publicado: (2018)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Qian, Xinye
Publicado: (2023)

Correction: Removal of Pharmaceutical Residues by Ferrate(VI)
por: Jiang, JiaQian, et al.
Publicado: (2013)

Correction to: NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth
por: Liu, Shu, et al.
Publicado: (2022)

Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma
por: Zheng, Ruiqi, et al.
Publicado: (2023)

Correction to: Aldose reductase deficiency inhibits LPS-induced M1 response in macrophages by activating autophagy
por: Cheng, Peng, et al.
Publicado: (2021)

Correction: IRE1 promotes neurodegeneration through autophagy-dependent neuron death in the Drosophila model of Parkinson’s disease
por: Yan, Cheng, et al.
Publicado: (2020)

Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
por: Lange, Andrzej, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l7fe99fh25h7cqjiq53duq0pv6